Running a Primary and Secondary Pharmaceutical Distributor Model: An Operations Playbook for Health Systems
By Drugzone Pharmaceuticals Inc 08-10-2026 1
In 2026, many health system pharmacies are rethinking how a single supply contract fits into a broader sourcing strategy.
Adding a second source is not only a contracting decision. Health systems that compare pharmaceutical wholesalers in New York for a secondary role need clear rules for ordering, receiving, and reporting. This playbook covers the operating model, not just vendor selection.
What a dual-source model asks of pharmacy operations
A second distributor means a second set of catalogs, accounts, invoices, and receiving routines. Without clear rules, the extra source adds friction instead of resilience. Staff need to know which source to use for which products, and why.
According to the American Society of Health-System Pharmacists (ASHP), 89 new shortages were recorded in 2025, the lowest annual total since 2006. Even so, 216 shortages were still active at the time of the year-end report, and the all-time high of 323 was reported in early 2024. — ASHP year-end shortages report, as covered by Becker's Hospital Review, January 2026
Those figures explain why a backup source has value. Fewer new shortages is good news, but active ones still change what pharmacy teams can order on a given day. A tested second source gives the team more options when that happens.
Design the operating model in five decisions
The strongest dual-source programs settle a few decisions in writing before the first order is placed.
- Define the role. Decide which product categories the secondary source supports, such as routine generic formulations, and which stay with the primary contract.
- Set routing rules. Write down when buyers order from the secondary source. Common triggers include a shortage, a delay, or a scheduled share of routine volume.
- Standardize receiving. Use the same receiving checks and documentation for both sources so staff follow one process.
- Align inventory targets. Review par levels so a second source does not create duplicate stock or expiring inventory.
- Review on a schedule. Meet quarterly to look at fill rates, response times, and any compliance questions.
Name one owner for the model. That person keeps the rules current and settles questions between buyers and pharmacy leadership.
Metrics keep the model honest. Track fill rate, order response time, and the number of exceptions logged each quarter. Share the results with pharmacy leadership so adjustments rest on data rather than impressions.
Vetting a secondary source for compliance and fit
A secondary source must meet the same standards as the primary one. Apply an identical vetting process and keep the documents on file.
Questions for a pharmaceutical distributor in New York
- Which state licenses and accreditations do you hold, and how can we verify them?
- Do you source directly from approved manufacturers, and how do you document provenance?
- How much of our formulary can you supply, and how do you handle substitutions?
- What does your onboarding and application review involve?
- How do you store and handle temperature-sensitive products?
- Who is our named account manager, and what is the escalation path?
Ask every candidate for written answers. Compare them side by side before anyone signs.
Document the outcome of every review. A short written record of why a source was approved helps during audits and contract renewals.
Keep traceability data consistent across suppliers
The Drug Supply Chain Security Act (DSCSA) sets national requirements for tracing certain prescription pharmaceutical products between trading partners. Its enhanced requirements center on electronic, interoperable data exchange. FDA granted staged exemptions, so compliance dates differ by trading partner type.
Per a law-firm summary of the FDA announcement, exemption compliance dates were August 27, 2025 for wholesale distributors and November 27, 2025 for dispensers with 26 or more full-time employees. — Akin Gump, Eye on FDA, October 2024
Those dates have now passed. In accordance with applicable regulations, confirm how each distributor shares transaction data with your health system. Two suppliers with different data formats can create reconciliation work for your team.
Choosing among pharmaceutical wholesalers in New York for a secondary role
A secondary source does not need to match the primary on every dimension. It needs to be dependable, compliant, and easy to work with. Score each candidate on credentials, sourcing, formulary overlap, responsiveness, and account support.
Consider an illustrative case. A health system pharmacy wants a backup for routine generic formulations. One candidate supplies a clear onboarding timeline, a named account manager, and written answers on sourcing. Another offers a brochure and a phone number.
The team has an obvious basis for choosing.
Start onboarding before you need the second source. Applications, credential checks, and test orders take time. A relationship that is already active can respond much faster than one that begins during a shortage.
Frequently asked questions
Q: Does adding a secondary distributor mean ending a national supply contract?
Not necessarily. Many health systems keep their primary contract and add a second source for selected products. Review your current contract terms with legal counsel before changing volumes.
Q: Which products suit a secondary source?
Routine generic formulations with strong formulary overlap are a common starting point. Specialty or temperature-sensitive products may need extra review. Confirm availability and handling requirements with the distributor first.
Q: What should health systems look for in pharmaceutical wholesalers in New York for a backup role?
Look for verifiable licensing, documented sourcing, traceability data, and responsive account support. Ask for references from institutions with a similar profile. Involve pharmacy leadership and compliance before you sign.
Q: How should receiving and documentation work with two suppliers?
Use one standard receiving process for both. Record the source, lot information, and any exceptions in the same system. Consistent records make audits and reconciliations simpler.
Q: When should a health system test a secondary relationship?
Test it before a disruption forces the issue. Place small routine orders to check ordering, delivery, and communication. Review the results with your buyers and adjust the routing rules.
Next steps for health system pharmacy leaders
Health systems that treat pharmaceutical wholesalers in New York as part of a written operating model gain options without adding confusion. Document the rules, vet each source, and review results every quarter. Share the outcomes with pharmacy leadership and compliance teams.
Drugzone Pharmaceuticals Inc., based in Nanuet, New York, is licensed to distribute in all 50 U.S. states. It is NABP-accredited, FDA-registered, and DSCSA 2025-compliant.
Drugzone supplies more than 2,000 SKUs through a network of 75+ manufacturers.
Its 20,000 sq. ft. temperature-controlled distribution facility and dedicated account management support recurring orders. Credentials and eligibility are subject to verification for licensed customers.
Tags : .....
